Geraldine joins LSP from Fortis, where she was responsible for European and US biotech research in her position as a Senior Equity Analyst. At Fortis, Geraldine spent 8 years covering the international biotech space, actively providing research on biotech companies in Europe as well as in the US. In addition to her coverage activities, Geraldine was responsible for a significant number of sector reports and was involved in several IPOs. At LSP, Geraldine will focus her attention on investing in publicly-traded biotech companies.
Martijn Kleijwegt, Managing Partner of LSP, comments: “It is a great pleasure to welcome Geraldine to our team. She brings a wealth of knowledge complementary to our current team of professionals and further expands our network into the global biotech community.” Mark Wegter, General Partner at LSP added: “Geraldine, whom we have known personally for many years, has a very strong track record as a leading biotech analyst in Europe. She will be joining Joep Muijrers and myself in our investment efforts in publicly-traded biotech companies, for which we have recently entered into a strategic investment relationship with APG Investments.”
About LSP
LSP (Life Sciences Partners) is a leading independent European investment firm, providing private and public equity financing to early- to mid-stage life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With EUR 400 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
About Geraldine O’Keeffe
Geraldine O’Keeffe is a Senior Equity Analyst at Fortis. Prior to joining the bank in 2000, she spent several years working at Biotrin, a medical diagnostic company based in Dublin, Ireland. During her time there, she played a key role in securing FDA approval for several products. She also spent time lecturing at the Dublin Institute of Technology and worked on a joint research project between the Max Planck Institute for BioPhysical Chemistry, Germany, and Oxford University, England. Geraldine has an MSc, a BSc and a diploma in Business Studies.
